The Secure use of TILDREN has not been evaluated in horses lower than four years of age. The effect of bisphosphonates over the skeleton of developing horses hasn't been researched; however, bisphosphonates inhibit osteoclast action which impacts bone turnover and may have an impact on bone development. The drug’s labeling https://horsemedicinestore.com/product/cuyulid/